A New Vision for Europe’s Bioeconomy in a Post-COVID World

Susan Finston
President, Finston Consulting LLC
Nigel Thompson
Vice Chairman, Princeton Capital Advisors

DOI:https://doi.org/10.5912/jcb971

Abstract:

In response to the COVID-19 global pandemic, the European Commission (EC) provided inclusive leadership, working as a team including EU member (national) officials, biopharmaceutical industry, NGOs, academic researchers and frontline health care personnel – acting with unprecedented collaboration and cohesion.  The emergence in early 2020 of the greatest public health threat in a century required new approaches and new collaborations. While the United States failed to provide leadership, the EU did not disappoint.